Search Results - "van der Horst, I."

Refine Results
  1. 1

    Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria by Koeze, J, Keus, F, Dieperink, W, van der Horst, I C C, Zijlstra, J G, van Meurs, M

    Published in BMC nephrology (20-02-2017)
    “…Acute kidney injury (AKI) is a serious complication of critical illness with both attributed morbidity and mortality at short-term and long-term. The incidence…”
    Get full text
    Journal Article
  2. 2

    Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis by Volbeda, M., Wetterslev, J., Gluud, C., Zijlstra, J. G., van der Horst, I. C. C., Keus, F.

    Published in Intensive care medicine (01-07-2015)
    “…Introduction Glucocorticosteroids (steroids) are widely used for sepsis patients. However, the potential benefits and harms of both high and low dose steroids…”
    Get full text
    Journal Article
  3. 3

    Trough anti-Xa activity after intermediate dose nadroparin for thrombosis prophylaxis in critically ill patients with COVID-19 and acute kidney injury by Eck, R. J., van de Leur, J. J. C. M., Wiersema, R., Cox, E. G. M., Bult, W., Spanjersberg, A. J., van der Horst, I. C. C., Lukens, M. V., Gans, R. O. B., Meijer, K., Keus, F.

    Published in Scientific reports (18-10-2022)
    “…Our objective was to assess the incidence of drug bioaccumulation in critically ill COVID-19 patients with AKI receiving intermediate dose nadroparin for…”
    Get full text
    Journal Article
  4. 4

    Telomere length loss due to smoking and metabolic traits by Huzen, J., Wong, L. S. M., Veldhuisen, D. J., Samani, N. J., Zwinderman, A. H., Codd, V., Cawthon, R. M., Benus, G. F. J. D., Horst, I. C.C., Navis, G., Bakker, S. J. L., Gansevoort, R. T., Jong, P. E., Hillege, H. L., Gilst, W. H., Boer, R. A., Harst, P.

    Published in Journal of internal medicine (01-02-2014)
    “…Objectives Human age‐dependent telomere attrition and telomere shortening are associated with several age‐associated diseases and poorer overall survival. The…”
    Get full text
    Journal Article
  5. 5

    Quality of life following adult veno-venous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review by Kurniawati, E. R., Rutjens, V. G. H., Vranken, N. P. A., Delnoij, T. S. R., Lorusso, R., van der Horst, I. C. C., Maessen, J. G., Weerwind, P. W.

    Published in Quality of life research (01-08-2021)
    “…Background Veno-venous extracorporeal membrane oxygenation (VV-ECMO) has been used successfully for the past decade in adult patients with acute respiratory…”
    Get full text
    Journal Article
  6. 6

    The effect of compliance with a perioperative goal-directed therapy protocol on outcomes after high-risk surgery: a before-after study by Boekel, M. F., Venema, C. S., Kaufmann, T., van der Horst, I. C. C., Vos, J. J., Scheeren, T. W. L.

    “…Perioperative goal-directed therapy is considered to improve patient outcomes after high-risk surgery. The association of compliance with perioperative…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Type 2 diabetes mellitus is associated with an imbalance in circulating endothelial and smooth muscle progenitor cell numbers by van Ark, J., Moser, J., Lexis, C. P. H., Bekkema, F., Pop, I., van der Horst, I. C. C., Zeebregts, C. J., van Goor, H., Wolffenbuttel, B. H. R., Hillebrands, J. L.

    Published in Diabetologia (01-09-2012)
    “…Aims/hypothesis Individuals with type 2 diabetes mellitus have increased rates of macrovascular disease (MVD). Endothelial progenitor cells (EPCs), circulating…”
    Get full text
    Journal Article
  10. 10

    Systematic overview and critical appraisal of meta‐analyses of interventions in intensive care medicine by Koster, T. M., Wetterslev, J., Gluud, C., Keus, F., Horst, I. C. C.

    Published in Acta anaesthesiologica Scandinavica (01-09-2018)
    “…Rationale Meta‐analysed intervention effect estimates are perceived to represent the highest level of evidence. However, such effects and the randomized…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis by Nielen, M M J, van Schaardenburg, D, Reesink, H W, Twisk, J W R, van de Stadt, R J, van der Horst-Bruinsma, I E, de Koning, M H M T, Habibuw, M R, Dijkmans, B A C

    Published in Annals of the rheumatic diseases (01-04-2006)
    “…Objective: To investigate the temporal relationship between onset of inflammation (as measured by secretory phospholipase A2 (sPLA2) and C reactive protein…”
    Get full text
    Journal Article
  13. 13

    Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis by van Denderen, J C, van der Paardt, M, Nurmohamed, M T, de Ryck, Y M M A, Dijkmans, B A C, van der Horst-Bruinsma, I E

    Published in Annals of the rheumatic diseases (01-12-2005)
    “…Objective: To assess the efficacy and safety of leflunomide in active ankylosing spondylitis (AS) compared with placebo in a 24 week pilot study. Methods: In a…”
    Get full text
    Journal Article
  14. 14

    Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis by de Vries, M K, van der Horst-Bruinsma, I E, Nurmohamed, M T, Aarden, L A, Stapel, S O, Peters, M J L, van Denderen, J C, Dijkmans, B A C, Wolbink, G J

    Published in Annals of the rheumatic diseases (01-04-2009)
    “…Immunogenicity, specifically the onset of antibodies against tumour necrosis factor (TNF) blocking agents, seems to play an important role in non-response to…”
    Get more information
    Journal Article
  15. 15

    Predictors of radiographic joint damage in patients with early rheumatoid arthritis by Jansen, L M A, van der Horst-Bruinsma, I E, van Schaardenburg, D, Bezemer, P D, Dijkmans, B A C

    Published in Annals of the rheumatic diseases (01-10-2001)
    “…OBJECTIVE To determine factors at diagnosis, associated with radiographic damage at diagnosis and after one year, in patients with early rheumatoid arthritis…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The effects of golimumab treatment on systolic and diastolic left ventricular function in ankylosing spondylitis by Heslinga, S C, Konings, T C, van der Horst-Bruinsma, I E, Kamp, O, van Halm, V P, de Bruin-Bon, Hacm, Peters, M J, Nurmohamed, M T

    Published in Biologics (01-01-2018)
    “…Diastolic left ventricular (LV) dysfunction appears more prevalent in ankylosing spondylitis (AS). The effects of tumor necrosis factor alpha (TNF-α) blocking…”
    Get full text
    Journal Article
  18. 18

    Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis by Nielen, M M J, van der Horst, A R, van Schaardenburg, D, van der Horst-Bruinsma, I E, van de Stadt, R J, Aarden, L, Dijkmans, B A C, Hamann, D

    Published in Annals of the rheumatic diseases (01-08-2005)
    “…Background: The anti-cyclic citrullinated peptide (CCP) test has a high sensitivity and specificity for rheumatoid arthritis, although CCP is not the…”
    Get full text
    Journal Article
  19. 19

    Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis by van der Heijde, D, Da Silva, J C, Dougados, M, Geher, P, van der Horst-Bruinsma, I, Juanola, X, Olivieri, I, Raeman, F, Settas, L, Sieper, J, Szechinski, J, Walker, D, Boussuge, M-P, Wajdula, J S, Paolozzi, L, Fatenejad, S

    Published in Annals of the rheumatic diseases (01-12-2006)
    “…Objective: To compare the efficacy, pharmacokinetics and safety of etanercept 50 mg once weekly with 25 mg twice weekly and placebo in patients with ankylosing…”
    Get full text
    Journal Article
  20. 20

    One year outcome of undifferentiated polyarthritis by Jansen, L M A, van Schaardenburg, D, van der Horst-Bruinsma, I E, Dijkmans, B A C

    Published in Annals of the rheumatic diseases (01-08-2002)
    “…Objective: To identify variables that can predict a progressive outcome after one year of follow up in patients presenting with undifferentiated polyarthritis…”
    Get full text
    Journal Article